NASDAQ · Biotechnology

Exelixis Inc (EXEL)

$54.45 -1.47%

Add alert

54 In band Daily RSI (14)

Moving averages

SMA 200$46.48+17.15%

Company profile

Exelixis, Inc., an oncology-focused biotechnology company, is focused on the discovery, development, and commercialization of new drugs to treat cancers in the United States. The company is headquartered in Alameda, California.

SectorHealthcare

IndustryBiotechnology

Market cap$12.70B

P/E ratio16.11

EPS$3.18

Beta0.422

Dividend yield0.00%

52-week high$57.57

52-week low$33.76

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 52 VRTX Vertex Pharmaceuticals Inc RSI 64 CRSP CRISPR Therapeutics AG RSI 54 IOVA Iovance Biotherapeutics Inc RSI 66 MRNA Moderna Inc RSI 67 VKTX Viking Therapeutics Inc RSI 49 SRPT Sarepta Therapeutics Inc RSI 67 EDIT Editas Medicine Inc RSI 52 NVAX Novavax Inc RSI 72 DNA Ginkgo Bioworks Holdings Inc - Class A RSI 44

Free forever

RSI alerts for EXEL

Get an email the moment Exelixis Inc crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 16 August 2026 at 3:37 AM EDT